Showing items 1 - 3 of 3

Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study

- Conway, A., Valerio, H., Dunlop, A., Montebello, M., Whitton, G., Reid, D., Lam, T., Alavi, M., Silk, D., Marshall, A. D., Treloar, C., Dore, G. J., Peacock, A., Grebely, J, ETHOS Engage Study Group,, Degenhardt, L., Hayllar, J., Harrod, M. E., Henderson, C., Read, P., Gilliver, R., Christmass, M.

Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: The ETHOS study

- Alavi, M., Micallef, M., Grebely, J., Fortier, E., Dunlop, A. J., Balcomb, A. C., Day, C. A., Treloar, C., Bath, N., Haber, P. S., Dore, G. J.

Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: the LiveRLife study

- Marshall, A. D., Micallef, M., Harvey, P., Dunlop, A., Jauncey, M., Read, P., Collie, T., Dore, G. J., Grebely, J., Erratt, A., Telenta, J., Treloar, C., Everingham, H., Jones, S. C., Bath, N., How-Chow, D., Byrne, J.

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit